Sanofi SA Given New €80.00 Price Target at Leerink Swann (SAN)
Equities research analysts at Leerink Swann lowered their price target on shares of Sanofi SA (EPA:SAN) from €83.00 ($113.70) to €80.00 ($109.59) in a research note issued to investors on Monday, Analyst Ratings Network reports. The firm currently has a “market perform” rating on the stock.
Sanofi SA (EPA:SAN) traded up 0.61% on Monday, hitting €73.71. The stock had a trading volume of 1,585,132 shares. Sanofi SA has a one year low of €65.91 and a one year high of €87.03. The stock’s 50-day moving average is €24.70 and its 200-day moving average is €25.11. The company has a market cap of €97.732 billion and a P/E ratio of 28.47.
Other equities research analysts have also recently issued reports about the stock. Analysts at Cowen and Company downgraded shares of Sanofi SA to a “market perform” rating in a research note to investors on Wednesday, August 21st. They now have a €57.00 ($78.08) price target on the stock, down previously from €63.00 ($86.30). Analysts at Sanford C. Bernstein cut their price target on shares of Sanofi SA from €59.00 ($80.82) to €57.00 ($78.08) in a research note to investors on Friday, August 2nd. They now have an “outperform” rating on the stock. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and twelve have given a buy rating to the company. The stock has an average rating of “Hold” and an average price target of €71.85 ($98.42).
Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.